Literature DB >> 27988271

Risk perception regarding drug use in pregnancy.

Sofia F Widnes1, Jan Schjøtt2.   

Abstract

Pregnant women, but also physicians, have unrealistically high perceptions of teratogenic drug effects. This may result in suboptimal treatment of disease and even influence decisions of whether to continue pregnancy. To attain more realistic teratogenic risk perceptions, several factors that influence this issue should be considered, and these are further discussed in this Clinical Opinion. Importantly, drug use may have several benefits, both for the pregnant woman's health and to avoid negative fetal effects of untreated maternal disease. A greater focus on this aspect may act to balance risk perceptions. Furthermore, both pregnant women and physicians need access to drug information sources that provide realistic risk estimates to increase confidence in appropriate drug use and prescribing. We suggest that access to decision support and individually tailored information provided by drug information centers may contribute to this goal.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  drug information centers; drug labeling; drug use; pregnancy; risk assessment; risk perception; teratogenic risk

Mesh:

Substances:

Year:  2016        PMID: 27988271     DOI: 10.1016/j.ajog.2016.12.007

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres.

Authors:  Agnes Kant; Loes de Vries; Leàn Rolfes
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

Review 2.  Norwegian drug information centres strongly promote person-centred and personalised medicine: a brief report on the achievements and strategy.

Authors:  Jan Schjøtt
Journal:  EPMA J       Date:  2019-04-30       Impact factor: 6.543

Review 3.  Medicines in pregnancy.

Authors:  Sarah Je Stock; Jane E Norman
Journal:  F1000Res       Date:  2019-06-20

4.  Use, Awareness, Knowledge and Beliefs of Medication During Pregnancy in Malaysia.

Authors:  Ahmad Habeeb Hattab Dala Ali Alani; Bassam Abdul Rasool Hassan; Azyyati Mohd Suhaimi; Ali Haider Mohammed
Journal:  Osong Public Health Res Perspect       Date:  2020-12

5.  Perceived Risk in Women with High Risk Pregnancy: A Qualitative Study.

Authors:  Zahra Shojaeian; Talat Khadivzadeh; Ali Sahebi; Hossein Kareshki; Fatemeh Tara
Journal:  Iran J Nurs Midwifery Res       Date:  2021-03-05

6.  Use of References in Responses from Scandinavian Drug Information Centres.

Authors:  Jan Schjøtt; Ylva Böttiger; Per Damkier; Linda Amundstuen Reppe; Jens Peter Kampmann; Hanne Rolighed Christensen; Olav Spigset
Journal:  Medicines (Basel)       Date:  2018-07-01

7.  SafeMotherMedicine: Aiming to Increase Women's Empowerment in Use of Medications During Pregnancy and Breastfeeding.

Authors:  Kristine Heitmann; Jan Schjøtt
Journal:  Matern Child Health J       Date:  2020-05

8.  Pregnant women's perceptions of risks and benefits when considering participation in vaccine trials.

Authors:  Elana Jaffe; Anne Drapkin Lyerly; Ilona Telefus Goldfarb
Journal:  Vaccine       Date:  2020-09-04       Impact factor: 3.641

9.  Antidepressant discontinuation before or during pregnancy and risk of psychiatric emergency in Denmark: A population-based propensity score-matched cohort study.

Authors:  Xiaoqin Liu; Nina Molenaar; Esben Agerbo; Natalie C Momen; Anna-Sophie Rommel; Angela Lupattelli; Veerle Bergink; Trine Munk-Olsen
Journal:  PLoS Med       Date:  2022-01-31       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.